Adma Biologics Cash Flow Statement (2011-2025) | ADMA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Dec2014 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-18.34M-18.82M-17.73M-16.50M-18.17M-13.75M-14.89M-11.79M-6.79M-6.37M2.56M10.59M17.81M32.06M35.91M111.90M26.90M34.22M36.43M49.38M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
0.78M0.81M0.69M1.21M1.64M1.19M1.31M1.07M1.11M1.64M1.70M1.75M2.14M2.86M3.18M5.43M4.62M4.96M5.05M5.39M
Deferred Taxes (Quarter)
84.28M3.42M1.62M4.80M-20.87M
Gains from Sales and Divestitures (Quarter)
0.09M0.09M0.09M0.38M0.38M1.41M2.73M0.63M0.81M1.03M1.20M1.15M1.39M1.70M1.89M1.46M1.62M1.84M1.88M
Gains from Investment Securities (Quarter)
1.44M1.66M1.76M0.01M0.01M1.19M1.19M0.01M0.01M1.73M1.73M0.00M1.10M2.78M0.26M1.66M1.78M1.87M
Non-cash Items (Quarter)
4.86M5.01M5.26M0.04M5.65M5.83M5.99M6.21M5.60M4.90M3.16M3.41M6.90M7.30M2.51M68.12M12.70M2.63M2.76M2.76M
Cash from Operations (Quarter)
-33.23M-32.26M-13.41M-33.47M-26.01M-12.83M-13.28M-7.38M-14.72M-6.06M11.98M17.60M-2.22M45.65M25.03M50.22M-19.68M21.14M13.29M35.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.44M0.46M0.49M0.50M0.58M0.34M0.98M0.49M0.49M0.69M0.72M0.70M0.25M0.23M0.25M0.22M0.19M0.16M0.17M0.20M
Amortization of Deferred Charges (Quarter)
1.05M0.98M0.97M0.98M0.99M0.99M0.88M
Depreciation & Amortization (CF) (Quarter)
1.23M1.33M1.42M1.52M1.59M1.72M1.86M1.94M2.03M2.10M2.09M2.11M2.11M2.05M1.94M1.94M1.97M2.06M2.02M2.05M
Change in Working Capital
Change in Receivables (Quarter)
2.12M8.18M-3.15M8.18M-2.95M-6.75M2.02M-5.40M11.01M10.21M-5.41M-3.90M22.20M-19.51M20.03M-0.14M49.41M10.31M27.95M20.76M
Change in Inventory (Quarter)
12.61M5.55M14.42M10.60M14.42M6.93M16.84M0.37M0.70M-2.21M1.34M9.79M4.83M2.08M-8.01M-1.57M1.95M19.28M5.20M9.80M
Change in Account Payables (Quarter)
1.08M-5.99M11.12M-4.85M1.69M-2.73M13.81M-11.97M-0.27M-0.87M-0.01M4.99M0.45M-1.86M1.62M3.94M0.14M9.27M-4.88M-2.20M
Change in Accured Expenses (Quarter)
-0.84M3.82M2.55M-5.31M-0.11M-1.35M1.10M-0.14M-1.35M6.09M0.14M-5.66M0.77M-0.56M-1.06M-0.29M-2.40M3.43M-1.02M0.70M
Other Working Capital Changes (Quarter)
-0.20M-0.10M0.16M-1.52M1.18M-0.12M-0.03M-0.28M-0.72M0.84M-0.11M0.23M-1.59M1.78M4.02M-1.52M2.60M-0.50M-1.12M0.55M
Investing Activities
Capital Expenditures (Quarter)
2.57M4.48M2.79M3.68M2.84M3.94M3.38M3.75M1.95M0.87M0.76M1.20M2.35M2.07M1.06M2.76M4.70M2.42M14.37M1.08M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
0.21M0.01M0.30M0.04M-0.01M0.02M0.10M0.19M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-2.57M-4.48M-2.79M-3.68M-2.84M-3.94M-3.38M-3.75M-1.95M-0.87M-0.76M-1.41M-2.36M-2.37M-1.10M-2.75M-4.72M-2.53M-14.37M-0.28M
Financing Activities
Other financing activities (Quarter)
2.38M0.40M72.002.35M-2.22M
Cash from Financing Activities (Quarter)
41.84M17.18M8.20M53.82M47.27M-0.32M-0.84M62.74M-0.65M0.24M0.42M-38.99M-1.45M-0.36M-25.47M-31.03M-7.13M0.05M-27.82M-9.12M
Additional items
Change in Cash (Quarter)
6.04M-19.56M-8.00M16.68M18.42M-17.09M-17.51M51.62M-17.32M-6.69M11.64M-22.80M-6.03M42.92M-1.54M16.44M-31.52M18.66M-28.90M26.25M
Free Cash Flow (Quarter)
-35.80M-36.74M-16.20M-37.14M-28.86M-16.77M-16.67M-11.13M-16.67M-6.93M11.23M16.40M-4.57M43.58M23.97M47.46M-24.38M18.72M-1.07M34.55M
Net Cash Flow (Quarter)
6.04M-19.56M-8.00M16.68M18.42M-17.09M-17.51M51.62M-17.32M-6.69M11.64M-22.80M-6.03M42.92M-1.54M16.44M-31.52M18.66M-28.90M26.25M